NAD+ (1000 mg) is a synthetic preparation of nicotinamide adenine dinucleotide, a coenzyme found in all living cells and essential to core biochemical processes. NAD⁺ is a dinucleotide composed of two nucleotides joined by phosphate groups, with a chemical formula of C₂₁H₂₇N₇O₁₄P₂ and a molecular weight of 663.43 g/mol.
It is supplied as a high-purity, lyophilized powder in a sterile vial for laboratory applications. Current NAD+ research focuses on its role in redox homeostasis, mitochondrial activity, and cellular energy transfer, particularly in systems that require efficient metabolic regulation.
NAD+ (1000mg) Key Features & Specs
- Category: Peptides for Research
- Strength: 1000mg
- CAS: 53-84-9
- Chemical Formula: C₂₁H₂₇N₇O₁₄P₂
- Molecular Weight: 663.43 g/mol
- Synonyms: Nicotinamide adenine dinucleotide, NAD
For laboratory research use only.
NAD+ (1000mg) Research Uses
NAD+ is studied for its central role in cellular metabolism and energy production. As a coenzyme, it functions as an electron carrier, cycling between oxidized (NAD+) and reduced (NADH) states, which supports key metabolic processes such as glycolysis, the tricarboxylic acid cycle, and oxidative phosphorylation.
Research has focused on how changes in NAD+ availability influence mitochondrial efficiency and ATP generation, particularly how cells adapt to metabolic stress or shifts in energy demand. NAD+ is also involved in cellular signaling pathways that regulate gene expression, inflammation, and stress responses.
NAD+ research has explored its role in maintaining cellular integrity, particularly in DNA repair and chromatin regulation, through interactions with enzymes such as PARPs and sirtuins. Studies also examine how altering NAD+ levels affects biological systems, including neuronal function, cardiovascular performance, and immune activity, in preclinical models.
NAD+ (1000mg) Insights & Observed Findings
Preclinical and in vitro research suggests that NAD⁺ availability may influence enzymatic processes involved in cellular repair. Outcomes vary with concentration, exposure conditions, and the biological systems studied.
In experimental systems:
- Increased NAD+ levels have been linked to enhanced sirtuin activity, which plays a role in cellular stress responses and metabolic regulation.
- Reduced NAD+ levels have been associated with impaired energy metabolism and decreased DNA repair efficiency.
Studies report measurable changes in cellular energy markers and metabolic activity, demonstrating NAD+’s influence on mitochondrial function and metabolic pathways. These findings provide insight into NAD+’s role in cellular processes but should not be interpreted as confirmed clinical outcomes.
NAD+ (1000mg) Handling & Storage
- Store NAD+ (1000 mg) at –20°C in a dry, controlled laboratory environment. Protect the vial from light and moisture prior to reconstitution.
- For reconstitution, use sterile purified water or a mild aqueous buffer appropriate for the experimental protocol.
- Reconstituted solutions intended for experimental work should be stored at 2–8°C and protected from light when not in use.
- To maintain sample integrity, minimize repeated freeze-thaw cycles.
- All handling and disposal procedures should follow institutional laboratory safety and regulatory guidelines.
Compliance Notice: This product is intended for laboratory research use only and is not approved for human or veterinary use. It is not intended for diagnostic, therapeutic, or clinical applications. Any reference to biological activity or potential effects is based solely on preclinical or in-vitro findings and should not be interpreted as validated clinical outcomes. Researchers are responsible for ensuring proper handling, storage, and disposal in accordance with institutional, federal, and international guidelines.
References
- Radenkovic D, Reason, Verdin E. Clinical evidence for targeting NAD therapeutically. Pharmaceuticals. 2020;13(9):247. doi:10.3390/ph13090247
- Iqbal T, Nakagawa T. The therapeutic perspective of NAD+ precursors in age-related diseases. Biochemical and Biophysical Research Communications. 2024;702:149590. doi:10.1016/j.bbrc.2024.149590
- Henderson JD, Quigley SNZ, Chachra SS, Conlon N, Ford D. The use of a systems approach to increase NAD+ in human participants. Npj Aging. 2024;10(1):7. doi:10.1038/s41514-023-00134-0
- Imai SI, Guarente L. NAD+ and sirtuins in aging and disease. Trends in Cell Biology. 2014;24(8):464-471. doi:10.1016/j.tcb.2014.04.002
- Covarrubias AJ, Perrone R, Grozio A, Verdin E. NAD+ metabolism and its roles in cellular processes during ageing. Nature Reviews Molecular Cell Biology. 2020;22(2):119-141. doi:10.1038/s41580-020-00313-x
- Abdellatif M, Sedej S, Kroemer G. NAD + metabolism in cardiac health, aging, and disease. Circulation. 2021;144(22):1795-1817. doi:10.1161/circulationaha.121.056589
- Yusri K, Jose S, Vermeulen KS, Tan TCM, Sorrentino V. The role of NAD+ metabolism and its modulation of mitochondria in aging and disease. Npj Metabolic Health and Disease. 2025;3(1):26. doi:10.1038/s44324-025-00067-0